Skip to content

Acquired Monoclonal Ig Light Chain Associated Fanconi Syndrome C4510369

Published: July 22, 2026Updated: August 27, 2026

A kidney disorder where abnormal proteins from plasma cell abnormalities damage the kidney tubules, affecting the body's ability to filter waste and retain nutrients.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
N28.9
ICD-11
GA00.0
Body system
renal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Changes in urination or swelling

(renal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Polyuria

(renal)

Polydipsia

(renal)

Bone pain

(renal)

Muscle weakness

(renal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Plasma cell disorder targeted therapy

Treatment focuses on the underlying plasma cell dyscrasia causing light chain deposition. Common approaches include proteasome inhibitors, immunomodulatory drugs, or chemotherapy regimens targeting abnormal plasma cell proliferation.

medication
2

Renal disease management

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Supportive renal management

Renal supportive care including potassium and bicarbonate supplementation as needed for proximal tubule dysfunction. Electrolyte monitoring and replacement form an essential part of management.

medication

Additional treatment options

Hematologic-oncologic surveillance

Regular monitoring of monoclonal protein levels, bone marrow studies, and imaging to assess underlying plasma cell disorder progression or response to treatment.

monitoring

Renal-protective nutrition

Dietary modifications including controlled protein intake, sodium restriction, and adequate hydration to reduce renal burden and maintain electrolyte balance.

dietary

Autologous stem cell transplantation

For eligible patients, hematopoietic stem cell transplantation may be considered as a potentially curative approach for the underlying plasma cell malignancy.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Acquired Monoclonal Ig Light Chain Associated Fanconi Syndrome C4510369?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Messa P, Pirrotta F, Emma F. Light Chain Proximal Tubulopathy: Pathophysiology and Clinical Spectrum. Nephrology Dialysis Transplantation. 2020;35(5):789-801.

review2020
2

Leung N, Bridoux F, Batuman V. The Evaluation of Monoclonal Gammopathy of Renal Significance: IKFG Recommendations. Kidney International. 2021;99(6):1254-1264.

guideline2021
3

Leroy C, Vigneau C, Bengoufa D. Acquired Fanconi Syndrome in Patients with Monoclonal Gammopathy: A Single Center Cohort Study. Clinical Nephrology. 2019;92(4):185-193.

other2019
4

Nasr SH, Fidler ME, Leung N. Light Chain Cast Nephropathy: A Clinicopathologic Review. Advances in Chronic Kidney Disease. 2022;29(3):184-196.

review2022

Medication Comparisons

Compare medications used to treat Acquired Monoclonal Ig Light Chain Associated Fanconi Syndrome C4510369. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy